SPONSOR
Bristol-Myers Squibb
Total Trials
15
Recruiting
15
Phases
Phase 3, Phase 1, Phase 2, Phase 3, Phase 4, Phase 1, Phase 2
Conditions studied: Psoriasis (PsO)Plaque PsoriasisAlzheimer DiseaseAgitationAdvanced Solid TumorAdvanced Breast CancerAdvanced Ovarian CancerPsoriasisMyelodysplastic Syndrome (MDS)Obstructive Hypertrophic Cardiomyopathy
NCT07017699
Recruiting
A Study to Assess Deucravacitinib Safety in Pregnancy
Psoriasis (PsO)
NCT06382987
Recruiting
A Study of the Comparative Effectiveness of Deucravacitinib in Adults With Plaque Psoriasis in Japan (RePhlect)
Plaque Psoriasis
NCT06937229 Phase 3
Recruiting
A Study to Evaluate the Long-term Efficacy and Safety of KarXT + KarX-EC for Agitation in Alzheimer's Disease (ADAGIO-3)
Alzheimer Disease
NCT06997029 Phase 1
Recruiting
A Phase 1 Study of BMS-986500 as Monotherapy or Combination Therapy in Advanced Solid Tumors
Advanced Solid Tumor
NCT05744466
Recruiting
A Real-world Observational Study to Compare Effectiveness of Deucravacitinib Vs Apremilast in Adults With Plaque Psoriasis
Psoriasis
NCT07008820
Recruiting
Patient Reported Outcomes and Patient Voice Among Patients Diagnosed With Low Risk Myelodysplastic Syndrome (LR-MDS) or Unexplained Anemia In Japan
Myelodysplastic Syndrome (MDS)
NCT06146660
Recruiting
A Study to Assess the Safety of Mavacamten in Korean Patients With Symptomatic Obstructive Hypertrophic Cardiomyopathy
Obstructive Hypertrophic Cardiomyopathy
NCT05076175 Phase 2, Phase 3
Recruiting
A Study Investigating Oral Ozanimod (RPC1063) in Pediatric Participants With Moderate to Severe Active Ulcerative Colitis
Colitis, Ulcerative
NCT07106762 Phase 2, Phase 3
Recruiting
Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease Progression on or After Immunotherapy
Urothelial Cancer
NCT06551129
Recruiting
Real-world Patient Reported Outcomes Among Patients Treated With Camzyos
Obstructive Hypertrophic Cardiomyopathy
NCT07004972 Phase 4
Recruiting
A Study of Mavacamten in Adults With Obstructive Hypertrophic Cardiomyopathy in India (ROVER)
Symptomatic Obstructive Hypertrophic Cardiomyopathy
NCT06448793
Recruiting
Patient and Physician Preference Study in Resectable, Non-small Cell Lung Cancer Treatments
Non-small Cell Lung Cancer (NSCLC)
NCT06697197 Phase 1, Phase 2
Recruiting
A Study of BMS-986482 Alone or as Combination Therapy in Participants With Advanced Solid Tumors
Advanced Solid Tumors
NCT06481306 Phase 1, Phase 2
Recruiting
A Study to Evaluate BMS-986470 in Healthy Volunteers and Participants With Sickle Cell Disease
Anemia, Sickle Cell
NCT07221149 Phase 2, Phase 3
Recruiting
A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Nivolumab in Combination With Chemotherapy in Participants With Previously Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma (ROSETTA Gastric-204)
Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma